CytomX Therapeutics
CTMX
#9418
Rank
NZ$98.88 M
Marketcap
$1.23
Share price
-3.96%
Change (1 day)
-55.04%
Change (1 year)

Earnings for CytomX Therapeutics (CTMX)

Earnings in 2024 (TTM): NZ$43.48 Million

According to CytomX Therapeutics 's latest financial reports the company's current earnings are NZ$0.13 Billion. , an increase over its 2023 earnings that were of -NZ$10.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CytomX Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 NZ$41.96 M-485.49%
2023 -NZ$10.89 Million-94.62%
2022 -NZ$0.21 Billion43.84%
2021 -NZ$0.15 Billion72.37%
2020 -NZ$81.61 Million-52.66%
2019 -NZ$0.18 Billion31.83%
2018 -NZ$0.14 Billion68.34%
2017 -NZ$77.67 Million-20.95%
2016 -NZ$98.26 Million73.99%
2015 -NZ$56.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion-671.69%๐Ÿ‡บ๐Ÿ‡ธ USA